Whitney Braddy, MD
Pain Medicine · Fayetteville, NCNPI 1215252481
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.0% of the total across 187 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 21.6% — the pattern of someone who eats at a lot of different presentations.
Across 187 payments — averaging $54.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Boston Scientific$2K
- Abbott$907
- Nevro Corp.$867
- SPR Therapeutics, Inc$672
- Averitas Pharma Inc.$531
- plus $3K from 29 others
What the payments were for
- Travel & lodging$3103%
- Food & beverage$9,91297%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 34 | $2,205 |
| Boston Scientific | 26 | $2,149 |
| Abbott | 15 | $907 |
| Nevro Corp. | 16 | $867 |
| SPR Therapeutics, Inc | 9 | $672 |
| Averitas Pharma Inc. | 6 | $531 |
| Saluda Medical Americas, Inc. | 4 | $500 |
| Relievant Medsystems, Inc. | 4 | $353 |
| Nalu Medical, Inc. | 4 | $328 |
| Scilex Pharmaceuticals Inc. | 13 | $182 |
| Collegium Pharmaceutical, Inc. | 10 | $158 |
| Wenzel Spine, Inc. | 1 | $154 |
| Avanos Medical | 2 | $149 |
| Interventional Pain Technologies Inc. | 1 | $134 |
| MML US, Inc. | 1 | $133 |
| GRT US Holding, Inc. | 1 | $117 |
| Biodelivery Sciences International, Inc. | 8 | $111 |
| Arbor Pharmaceuticals, Inc. | 6 | $98 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $97 |
| Stimwave Technologies Incorporated | 5 | $83 |
| Vertical Pharmaceuticals, LLC | 2 | $41 |
| Pfizer | 2 | $32 |
| Kaleo, Inc. | 2 | $29 |
| Daiichi Sankyo Inc. | 2 | $26 |
| Globus Medical | 1 | $20 |
| Fidia Pharma USA Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $18 |
| AbbVie | 1 | $16 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
| Vertex | 1 | $14 |
| Pernix Therapeutics Holdings, Inc. | 1 | $14 |
| Pacira Therapeutics, Inc. | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $12 |
| Shionogi Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$838
- WaveWriter Alpha Prime 16$679
- SPRINT PNS System$535
- Qutenza$510
- Senza$386
- INTELLIS ADAPTIVESTIM$385
- Evoke$384
- SYNCHROMEDII$382
- KYPHON EXPRESS II KYPHOPAK TRAY$314
- ETERNA$310
- CLINICAL TRIAL PRODUCT$290
- Nalu Neurostimulation System$279
- PROCLAIM$174
- Varilift$154
- Superion Indirect Decompression System$145
- ReActiv8$133
- INCEPTIV$131
- OSTEOCOOL RF ABLATION SYSTEM$129
- Evoke SCS$116
- Proclaim IPG$116
How this compares
$10,223 in reported general payments places this provider in the 75th percentile of 182 pain medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 471 | $8,982 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 282 | $7,369 |
| BelbucaBuprenorphine Hcl | 11 | $4,665 |
| Pregabalin | 330 | $3,897 |
| Gabapentin | 199 | $2,240 |
| Oxycodone Hcl | 57 | $1,071 |
| Lidocaine | 12 | $869 |
| Celecoxib | 24 | $734 |
| Tramadol Hcl | 113 | $667 |
| Methocarbamol | 39 | $597 |
| Morphine Sulfate ErMorphine Sulfate | 17 | $529 |
| Tizanidine Hcl | 49 | $485 |
| Cyclobenzaprine Hcl | 18 | $134 |
| Baclofen | 13 | $116 |
| Diazepam | 12 | $17 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca | $158 | $4,66511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 182 pain medicine providers in North Carolina.
Other pain medicine in Fayetteville
- James NorthWinston Salem$721K
- Leonardo KapuralWinston Salem$523K
- Christopher GilmoreWinston Salem$457K
- Richard RauckWinston Salem$431K
- Courtney AumanJacksonville$186K
- Jacob WangCharlotte$162K
- Aashish KumarCharlotte$160K
- Javid BakshAsheville$116K
- David ZubLeland$97K
- James DeeringCharlotte$93K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.